TUESDAY, Nov. 12, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Emrosi (minocycline ...

U.S. FDA approved Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea in adults; launch expected in late Q1 or early Q2 of 2025 ...

The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.

As more consumers seek solutions for redness-prone skin, the demand for effective, gentle ingredients is soaring. From environmental stressors to common irritants like acne and rosacea, sensitive skin ...

Discover a study regime that included a treatment serum, a redness-reducing moisturizer, and sunscreen that showed promising ...

"Treatment with topical ivermectin may improve the symptoms of rosacea through modulation of the skin microbiome beyond decreasing Demodex," the authors concluded. "The results of this study,” they ...

The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...

The FDA approved Emrosi (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions of ...

QUESTION: I have suffered from acne and rosacea since I was a teenager. Back then, my dermatologist recommended benzoyl ...

Fortress Biotech, Inc. (NASDAQ: FBIO) announced through its majority-controlled subsidiary, Journey Medical Corporation, that the U.S. Food and Drug Administration (FDA) has approved Emrosi™ ...

Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...